Hepatic Oncology Archives - Oncology Central Oncology Central

Must read

26 Sep 2017 Hepatic Oncology
Controversies of preoperative portal vein embolization

24 Jul 2017 Hepatic Oncology
Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection
27 Feb 2017 Hepatic Oncology
Radioembolization for hepatocellular carcinoma: current role and future directions – the medical oncologist’s perspective
8 Dec 2016
Immune checkpoint inhibitors for hepatocellular carcinoma
11 Apr 2016
The clinical role of ‘liquid biopsy’ in hepatocellular carcinoma
15 Mar 2016
Liver transplantation in the management of perihilar cholangiocarcinoma
2 Mar 2016
Liver cancer screening in high-risk populations

Must watch

13 Feb 2019 Lung
Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Stay up to date

Upcoming event

ESMO Breast Cancer 2019 – annual congress

May 2, 2019 – May 4, 2019

Berlin, Germany

View all

Upcoming event

American Society of Clinical Oncology (ASCO) annual meeting

May 31, 2019 – June 4, 2019

IL, USA

View all

Tweets

Oncology Central @OncologyCentral·

Novel #drug discovery program uses a Darwinian approach to develop drugs that target #cancer’s lethal ability to evolve resistance to current treatments. Click the image below for the full news story: https://t.co/gMI8hfLq7p

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Controversies of preoperative portal vein embolization

Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection

Radioembolization for hepatocellular carcinoma: current role and future directions – the medical oncologist’s perspective

Immune checkpoint inhibitors for hepatocellular carcinoma

The clinical role of ‘liquid biopsy’ in hepatocellular carcinoma

Liver transplantation in the management of perihilar cholangiocarcinoma

Liver cancer screening in high-risk populations

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

New horizons in ablation therapy for hepatocellular carcinoma

How endoplasmic reticulum stress contributes to obesity-driven hepatic tumorigenesis

Liver transplantation in treatment of colorectal liver metastases

Radiotherapy for liver tumors

Hepatocellular adenoma management: advances but still a long way to go

Liver transplantation for metastatic neuroendocrine tumors

Liver transplantation for advanced hepatocellular carcinoma: how far can we go?

The biological and clinical challenge of liver cancer heterogeneity

Nonsurgical multidisciplinary approach for recurrent hepatocellular carcinoma after surgical resection

Liver cancer oncogenomics: opportunities and dilemmas for clinical applications

Immune play: defending the liver

Hepatocellular carcinoma risk scores: ready to use in 2015?

The evolving field of intrahepatic cholangiocarcinoma

Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer

Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment

Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI

Login

Hepatic Oncology

Must read

Controversies of preoperative portal vein embolization

Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection

Radioembolization for hepatocellular carcinoma: current role and future directions – the medical oncologist’s perspective

Immune checkpoint inhibitors for hepatocellular carcinoma

The clinical role of ‘liquid biopsy’ in hepatocellular carcinoma

Liver transplantation in the management of perihilar cholangiocarcinoma

Liver cancer screening in high-risk populations

Must watch

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Emerging treatment options for pancreatic cancer with Thomas Seufferlein

Tamoxifen, SERMs and sustainable medicine

Seven challenges in immuno-oncology

The importance of a multidisciplinary team in the care of head and neck cancer

New horizons in ablation therapy for hepatocellular carcinoma

How endoplasmic reticulum stress contributes to obesity-driven hepatic tumorigenesis

Liver transplantation in treatment of colorectal liver metastases

Radiotherapy for liver tumors

Hepatocellular adenoma management: advances but still a long way to go

Liver transplantation for metastatic neuroendocrine tumors

Liver transplantation for advanced hepatocellular carcinoma: how far can we go?

The biological and clinical challenge of liver cancer heterogeneity

Nonsurgical multidisciplinary approach for recurrent hepatocellular carcinoma after surgical resection

Liver cancer oncogenomics: opportunities and dilemmas for clinical applications

Immune play: defending the liver

Hepatocellular carcinoma risk scores: ready to use in 2015?

The evolving field of intrahepatic cholangiocarcinoma

Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer

Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment

Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI

Stay up to date

Oncology Central Newsletter